View of Body mass index as a predictor of the efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and other solid tumors

Return to Article Details Body mass index as a predictor of the efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and other solid tumors Download Download PDF